Cargando…
COVID-19 Biomarkers for Critically Ill Patients: A Compendium for the Physician
Background: SARS-CoV-2 clinical manifestation and progression are variable and unpredictable, hence the importance of considering biomarkers in clinical practice that can be useful for both diagnosis and prognostic evaluation. This review aims to summarize, for intensive care physicians, the most re...
Autores principales: | Arturi, Federica, Melegari, Gabriele, Giansante, Antonio, Giuliani, Enrico, Bertellini, Elisabetta, Barbieri, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366869/ https://www.ncbi.nlm.nih.gov/pubmed/37489362 http://dx.doi.org/10.3390/neurolint15030056 |
Ejemplares similares
-
Point-of-care pancreatic stone protein measurement in critically ill COVID-19 patients
por: Melegari, Gabriele, et al.
Publicado: (2023) -
Intensive Care Patients from the First COVID-19 Wave: One-Year Survival after Tocilizumab Treatment
por: Melegari, Gabriele, et al.
Publicado: (2021) -
COVID-19: Relative Risk of Non-Vaccinated to Vaccinated Individuals
por: Barbieri, Davide, et al.
Publicado: (2022) -
Novel coronavirus (2019-nCov): do you have enough intensive care units?
por: Melegari, G., et al.
Publicado: (2020) -
Novel coronavirus (2019-nCov): do you have enough intensive care units?
por: Melegari, G., et al.
Publicado: (2020)